TY - JOUR
KW - 3291:Immunological Disorders
KW - 3363:Medical Treatment of Physical Illness
KW - Adulthood (18 yrs & older)
KW - antibodies
KW - antiretroviral therapy
KW - article
KW - buprenorphine
KW - Drug Therapy
KW - Empirical Study
KW - Female
KW - Hepatitis
KW - Hepatitis C
KW - HIV
KW - Human
KW - human immunodeficiency virus
KW - Longitudinal Study
KW - Male
KW - Quantitative Study
KW - Retrospective Study
KW - Treatment Outcomes
KW - US
AU - Lynn E. Taylor
AU - Michaela A. Maynard
AU - Peter D. Friedmann
AU - Cynthia J. MacLeod
AU - Josiah D. Rich
AU - Timothy P. Flanigan
AU - Diana L. Sylvestre
A1 - 
BT - Journal of Addiction Medicine
C5 - Opioids & Substance Use
CP - 3
IS - 3
JF - Journal of Addiction Medicine
PB - Lippincott Williams & Wilkins
PY - 2012
SN - 1932-0620, 1932-0620
SP - 179
EP - 185
EP - 
T1 - Buprenorphine for human immunodeficiency virus/hepatitis C virus coinfected patients: Does it serve as a bridge to hepatitis C virus therapy?
T2 - Journal of Addiction Medicine
TI - Buprenorphine for human immunodeficiency virus/hepatitis C virus coinfected patients: Does it serve as a bridge to hepatitis C virus therapy?
U1 - Opioids & Substance Use
VL - 6
VO - 1932-0620, 1932-0620
Y1 - 2012
ER -